S&P Biotech SPDR ETF

XBI

S&P Biotech SPDR ETF (XBI)

Q: What is S&P Biotech SPDR ETF (XBI) share price today?

S&P Biotech SPDR ETF (XBI) share price today is $116.74

Q: Can Indians buy S&P Biotech SPDR ETF (XBI) shares?

Yes, Indians can buy S&P Biotech SPDR ETF (XBI) shares. As per RBI rule, an Indian citizen can invest 250,000 dollars a year in foreign markets.

Q: How can I buy S&P Biotech SPDR ETF (XBI) shares from India?

Three ways to invest in S&P Biotech SPDR ETF (XBI) stocks from India are 1.Investment through apps: INDmoney is one of the leading apps that help you invest in S&P Biotech SPDR ETF (XBI) stocks from India 2.Investment through Indian brokers tied up with a foreign broker 3.Investment by opening an account with a Foreign broker

Q: Can Fractional shares of S&P Biotech SPDR ETF (XBI) be purchased?

You can buy just a fraction of S&P Biotech SPDR ETF (XBI) shares.

Q: What are the documents required to start investing in S&P Biotech SPDR ETF (XBI) stocks?

You will need a proof of Identification (PAN, Aadhaar etc) and proof of address (Aadhaar, Voter ID etc) to invest in S&P Biotech SPDR ETF (XBI) stocks . The entire process is paperless and can be completed seamlessly.

$116.742.21%▲

Key Stats

Open	$119.49
Today Low/High	$115.07 / $120.46
52 Week Low/High	$115.4 / $174.74
Market Cap	$6.93B
Expense Ratio	0.0035
Total Assets	$7.36B
Yield	0.23

Top 10 Holdings

ChemoCentryx Inc	2.01%
Dicerna Pharmaceuticals Inc	1.38%
Seres Therapeutics Inc	1.09%
Cytokinetics Incorporated	1.08%
Acceleron Pharma Inc	1.06%
Avid Bioservices Inc	0.98%
Apellis Pharmaceuticals Inc	0.97%
Seagen Inc	0.95%
ACADIA Pharmaceuticals Inc	0.92%
Ligand Pharmaceuticals Incorporated	0.92%

Market Cap
Sector
Assets

Region breakup

North America	98.36%
Europe Developed	1.06%
United Kingdom	0.58%

About the ETF

About State Street

State Street has 112 ETFs with total asset size of $982.59B.

US Healthcare ETF

This ETF invests in companies involved in the medical and healthcare industries.

SPDR S&P Biotech ETF

This ETF has 99.95% of its total asset in Stocks and it primarily focuses on the Healthcare sector, in the North America region.

Assets Managed

SPDR S&P Biotech ETF was started on 2006 and has accumulated $7.36B in assets managed.

Discover more

Arrow Dow Jones Global Yield ETF

$14.3742

-1.85%▲

Direxion Daily FTSE China Bull 3x Shares ETF

$9.8

-8.33%▲

US Consumer Services iShares

$83.8

-2.24%▲

First Trust NYSE Arca Biotech ETF

$158.74

-0.18%▲

Direxion Daily S&P 500 Bear 3X Shares ETF

$18.73

+6.78%▲

iShares MSCI Min Vol Global ETF

$104.78

-1.44%▲

Russell 2000 iShares ETF

$222.85

-3.77%▲

Explore all

Frequently Asked Questions

What is S&P Biotech SPDR ETF (XBI) share price today?

Can Indians buy S&P Biotech SPDR ETF (XBI) shares?

How can I buy S&P Biotech SPDR ETF (XBI) shares from India?

Can Fractional shares of S&P Biotech SPDR ETF (XBI) be purchased?

What are the documents required to start investing in S&P Biotech SPDR ETF (XBI) stocks?

Markets:

Stocks:

Best Mutual Funds:

Mutual Funds:

US Stocks:

US Stocks Guide:

Bonds:

Tools:

Explore AMCs:

INDmoney, INDwealth, IND.app, IND.money, INDsave.com are brand and product of Finzoom Investment Advisors (P) Limited.

Finzoomers Services Private Limited - [Registered address: 624-625, 6th Floor, Suncity Success Tower, Golf Course Extension Road, Sector - 65 Gurugram – HR- 122005] [IRDAI Corporate Agent (Composite) Registration No- CA0744 Validity till - 02/03/2024] [Principal Officer- Mr. Ankur Goyal, Principal Officer email id- po@finzoomers.in] [CIN: U74990HR2020PTC086201] [GST No: 06AAECF0692E1ZV] [Email id: insurancesupport@indmoney.com]

Finzoom Investment Advisors Private Limited makes no warranties or representations, express or implied, on products and services offered through the platform. It accepts no liability for any damages or losses, however, caused in connection with the use of, or on the reliance of its advisory or related services.

Past performance is not indicative of future returns. Please consider your specific investment requirements, risk tolerance, goal, time frame, risk and reward balance and the cost associated with the investment before choosing a fund, or designing a portfolio that suits your needs. Performance and returns of any investment portfolio can neither be predicted nor guaranteed.

Mutual Fund investments are subject to market risks, read all scheme related documents carefully.

Marketing and distribution of various financial products such as loans, deposits and Insurance are powered by Finzoomers Services Private Limited.

[SEBI RIA Registration No: INA100012190] [Type of Registration: Non-Individual] [Validity of registration: December 17, 2018-Perpetual] [Address: 616, 6th Floor, Suncity Success Tower, Golf Course Extension Road, Sector – 65, Gurugram, Haryana- 122005] [Corresponding SEBI local office address: Securities and Exchange Board of India, Local Office, First Floor, SCO 127-128, Sector 17C, Chandigarh-160017][Principal Officer details: Mr. Gaurav Sharma, Email id: principalofficer@indmoney.com]

[ARN - 151913] [Platform Partner : BSE (Member code-24801)] [CIN - U67190HR2018PTC073294] [GST No : 06AADCF3538Q1Z8]

US stocks watchlist

Mutual Funds watchlist